219 related articles for article (PubMed ID: 8030708)
1. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
[TBL] [Abstract][Full Text] [Related]
2. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
Weiner CP; Widness JA
Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
[TBL] [Abstract][Full Text] [Related]
4. Current clinical management of anti-Kell alloimmunization in pregnancy.
Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
[TBL] [Abstract][Full Text] [Related]
5. Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
Li S; He Z; Mo C; Ji Y; Luo Y; Fang Q; Gao Y
Transfusion; 2021 Jun; 61(6):1908-1915. PubMed ID: 33938570
[TBL] [Abstract][Full Text] [Related]
6. Management of pregnancies complicated by anti-Kell isoimmunization.
McKenna DS; Nagaraja HN; O'Shaughnessy R
Obstet Gynecol; 1999 May; 93(5 Pt 1):667-73. PubMed ID: 10912964
[TBL] [Abstract][Full Text] [Related]
7. [Isoimmunization to Kell factor, during pregnancy].
Krug A; Bianchi R; Cornejo A; Farias S; Fuentes L
Rev Chil Obstet Ginecol; 1988; 53(4):198-200. PubMed ID: 3155245
[No Abstract] [Full Text] [Related]
8. Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?
van den Akker ES; Klumper FJ; Brand A; Kanhai HH; Oepkes D
Vox Sang; 2008 Jul; 95(1):66-9. PubMed ID: 18435678
[TBL] [Abstract][Full Text] [Related]
9. [Kell alloimmunization in pregnancy].
Gariod S; Brossard Y; Poissonnier MH; Vuilliez B; Deutsch V; Jouk PS; Pons JC
J Gynecol Obstet Biol Reprod (Paris); 2004 Nov; 33(7):637-48. PubMed ID: 15550883
[TBL] [Abstract][Full Text] [Related]
10. Non-anti-D antibodies in red-cell alloimmunization.
Moise KJ
Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):75-81. PubMed ID: 10986438
[TBL] [Abstract][Full Text] [Related]
11. Erythroblastosis fetalis produced by anti-k.
Bowman JM; Harman FA; Manning CR; Pollock JM
Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of maternal serum testing for detection of fetal anemia in red blood cell alloimmunization.
Moise KJ; Perkins JT; Sosler SD; Brown SJ; Saade G; Carpenter RJ; Thorp JA; Ludomirski A; Wilkins IA; Grannum PA
Am J Obstet Gynecol; 1995 Mar; 172(3):1003-9. PubMed ID: 7892839
[TBL] [Abstract][Full Text] [Related]
13. Obstetric outcome after RhD and Kell testing.
Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
[TBL] [Abstract][Full Text] [Related]
14. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
van Wamelen DJ; Klumper FJ; de Haas M; Meerman RH; van Kamp IL; Oepkes D
Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin.
Dhodapkar KM; Blei F
J Pediatr Hematol Oncol; 2001 Jan; 23(1):69-70. PubMed ID: 11196277
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive tests to predict fetal anemia in Kell-alloimmunized pregnancies.
van Dongen H; Klumper FJ; Sikkel E; Vandenbussche FP; Oepkes D
Ultrasound Obstet Gynecol; 2005 Apr; 25(4):341-5. PubMed ID: 15736218
[TBL] [Abstract][Full Text] [Related]
17. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
Wenk RE; Goldstein P; Felix JK
Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.
Mari G; Deter RL; Carpenter RL; Rahman F; Zimmerman R; Moise KJ; Dorman KF; Ludomirsky A; Gonzalez R; Gomez R; Oz U; Detti L; Copel JA; Bahado-Singh R; Berry S; Martinez-Poyer J; Blackwell SC
N Engl J Med; 2000 Jan; 342(1):9-14. PubMed ID: 10620643
[TBL] [Abstract][Full Text] [Related]
19. Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jr
Ohto H; Denomme GA; Ito S; Ishida A; Nollet KE; Yasuda H
Transfus Apher Sci; 2020 Oct; 59(5):102949. PubMed ID: 32994126
[TBL] [Abstract][Full Text] [Related]
20. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
